These mechanistic findings parallel the intrinsic steroidogenic abnormalities in PCOS, where increased CYP17 activity drives excess androgen biosynthesis and insufficient aromatase activity fails to counterbalance it. Here, CYP17A1 is linked to polycystic ovary syndrome.